Response to Letter Regarding Article, “Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications: Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial”
- 21 September 2010
- journal article
- reply
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 122 (12)
- https://doi.org/10.1161/circulationaha.110.951897
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic ComplicationsCirculation, 2010
- Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialThe Lancet, 2009
- Bivalirudin during Primary PCI in Acute Myocardial InfarctionNew England Journal of Medicine, 2008
- Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive ManagementJama-Journal Of The American Medical Association, 2007
- Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary RevascularizationREPLACE-2 Randomized TrialJama-Journal Of The American Medical Association, 2004